These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

599 related items for PubMed ID: 16296873

  • 1. Parathyroid hormone as an anabolic skeletal therapy.
    Rubin MR, Bilezikian JP.
    Drugs; 2005; 65(17):2481-98. PubMed ID: 16296873
    [Abstract] [Full Text] [Related]

  • 2. Combination/sequential therapies for anabolic and antiresorptive skeletal agents for osteoporosis.
    Bilezikian JP, Rubin MR.
    Curr Osteoporos Rep; 2006 Mar; 4(1):5-13. PubMed ID: 16527002
    [Abstract] [Full Text] [Related]

  • 3. Parathyroid hormone as an anabolic therapy for women and men.
    Bilezikian JP, Rubin MR, Finkelstein JS.
    J Endocrinol Invest; 2005 Mar; 28(8 Suppl):41-9. PubMed ID: 16329201
    [Abstract] [Full Text] [Related]

  • 4. The use of parathyroid hormone in the treatment of osteoporosis.
    Girotra M, Rubin MR, Bilezikian JP.
    Rev Endocr Metab Disord; 2006 Jun; 7(1-2):113-21. PubMed ID: 17043762
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Anabolic skeletal therapy for osteoporosis.
    Girotra M, Rubin MR, Bilezikian JP.
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):745-54. PubMed ID: 17117299
    [Abstract] [Full Text] [Related]

  • 8. Mixed-treatment comparison of anabolic (teriparatide and PTH 1-84) therapies in women with severe osteoporosis.
    Migliore A, Broccoli S, Massafra U, Bizzi E, Frediani B.
    Curr Med Res Opin; 2012 Mar; 28(3):467-73. PubMed ID: 22256908
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combination antiresorptive and osteoanabolic therapy for osteoporosis: we are not there yet.
    Cusano NE, Bilezikian JP.
    Curr Med Res Opin; 2011 Sep; 27(9):1705-7. PubMed ID: 21740288
    [Abstract] [Full Text] [Related]

  • 12. PTH (1-34): a novel anabolic drug for the treatment of osteoporosis.
    Holick MF.
    South Med J; 2005 Nov; 98(11):1114-7. PubMed ID: 16353381
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anabolic therapy for osteoporosis: parathyroid hormone.
    Cosman F.
    Curr Osteoporos Rep; 2005 Dec; 3(4):143-9. PubMed ID: 16303114
    [Abstract] [Full Text] [Related]

  • 18. Parathyroid Hormone and Parathyroid Hormone-Related Protein Analogs in Osteoporosis Therapy.
    Leder BZ.
    Curr Osteoporos Rep; 2017 Apr; 15(2):110-119. PubMed ID: 28303448
    [Abstract] [Full Text] [Related]

  • 19. Biologicals in osteoporosis: teriparatide and parathyroid hormone in women and men.
    Devogelaer JP, Boutsen Y, Manicourt DH.
    Curr Osteoporos Rep; 2010 Sep; 8(3):154-61. PubMed ID: 20563900
    [Abstract] [Full Text] [Related]

  • 20. Management of postmenopausal osteoporosis and the prevention of fractures.
    Gambacciani M, Levancini M.
    Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.